G. J. Kirkovits, R. S. Zimmerman, M. T. Huggins, V. M. Lynch, J. L. Sessler
150 mL). The aqueous layer was adjusted to pH 10Ϫ11 using 15-Crown-5-dipyrrolylquinoxaline (2): The intermediate diamine 17
FULL PAPER
Na2CO3 and extracted with CH2Cl2 (3 ϫ 150 mL). The combined
was synthesized from 13 (2.50 g, 6.98 mmol) according to the gen-
eral procedure given above. This was then treated with 20 (0.60 g,
organic extracts were dried (MgSO4) and concentrated in vacuo to
afford 14 as a yellow solid (3.61 g, 78%). 1H NMR (250 MHz, 3.2 mmol). Product 2 was obtained, pure, as a fine brown powder
CDCl3): δ ϭ 2.33 (br. s, 1 H, NH), 2.76Ϫ2.82 (m, 4 H, CH2N), (1.44 g, 100%). 1H NMR (250 MHz, CDCl3): δ ϭ 3.78Ϫ3.85 (m,
3.59Ϫ3.72 (m, 8 H, CH2O), 3.84Ϫ3.92 (m, 4 H, CH2O), 4.24Ϫ4.29
12 H, CH2O), 4.06Ϫ4.09 (m, 4 H, PhOCH2), 6.26 (m, 2 H, pyr-
(m, 4 H, PhOCH2), 7.30 (s, 1 H, Ph-H), 7.31 (s, 1 H, Ph-H) ppm. H), 6.54 (m, 2 H, pyr-H), 6.93 (s, 2 H, Ph-H), 6.98 (m, 2 H, pyr-
13C NMR (62 MHz, CDCl3): δ ϭ 49.4, 68.3, 68.7, 69.3, 69.6, 70.1,
H), 9.62 (br. s, 2 H, pyr-NH) ppm. 13C NMR (62 MHz, CDCl3):
δ ϭ 68.2, 69.1, 70.3, 71.3, 106.9, 109.8, 111.2, 120.9, 129.3, 136.8,
70.6, 70.7, 107.8, 108.1, 136.5, 151.5, 151.6 ppm. HRMS (CIϩ):
calcd. for C16H24N3O9 [M ϩ H]ϩ 402.1513; found m/z: 402.1510. 141.9, 151.5 ppm. HRMS (CIϩ): calcd. for C24H27N4O5 [M ϩ H]ϩ:
C16H23N3O9: calcd. C 47.88, H 5.78, N 10.47; found C 47.94, H
5.87, N 10.37.
451.1981; found m/z: 451.1964. C24H26N4O5: calcd. C 63.99, H
5.82, N 12.44; found C 63.73, H 5.72, N 12.22. UV/Vis: λmax
(CH3CN, ε/Ϫ1 cmϪ1) ϭ 269 (27,800), 402 (17,700) nm.
Dinitrobenzoaza-15-crown-5 (15): 15 was synthesized from
benzoaza-15-crown-5 (11) (1.24 g, 4.6 mmol). Workup in the man-
ner described for 14, afforded 15 as a yellow solid (1.15 g, 44%).
1H NMR (250 MHz, CDCl3): δ ϭ 2.50 (br. s, 1 H, NH), 2.79Ϫ2.83
(m, 4 H, CH2N), 3.73Ϫ3.76 (m, 4 H, CH2O), 3.88Ϫ3.92 (m, 4 H,
CH2O), 4.20Ϫ4.23 (m, 4 H, PhOCH2), 7.27 (s, 2 H, Ph-H) ppm.
13C NMR (62 MHz, CDCl3): δ ϭ 49.2, 68.1, 68.8, 70.5, 107.5,
136.7, 151.6 ppm. HRMS (CIϩ): calcd. for C14H19N3O8 [M ϩ H]ϩ
358.1250; found m/z: 358.1252. C14H19N3O8: calcd. C 47.06, H
5.36, N 11.76; found C 47.02, H 5.35, N 11.73.
Crystallization of 2 and its KCF3SO3 Complex: Receptor 2 was dis-
solved in boiling acetone and then allowed to cool to room temp.
Pale yellow crystals of 2, suitable for X-ray diffraction analysis,
were obtained by letting stand overnight. The complex was ob-
tained by dissolving 2 and excess KCF3SO3 in MeCN at ambient
temperature, and allowing vapor diffusion of Et2O in a screw-
capped vial. In this manner, amber crystals, suitable for X-ray dif-
fraction analysis, were obtained after several days.
General Procedure. Synthesis of 3n-Crown-n-dipyrrolylquinoxalines
1؊4 and 6,7-Dimethoxy-2,3-bis(1H-pyrrol-2-yl)quinoxaline (21):
Aza-18-crown-6-dipyrrolylquinoxaline (3): The intermediate di-
amine 18 was synthesized from 14 (2.01 g, 5.0 mmol) according to
the general procedure given above. This was then treated with 20
(0.43 g, 2.3 mmol) to yield the crude product as the acetate salt.
Therefore, the workup was modified in the following manner: The
reaction mixture was redissolved in a mixture of CH2Cl2 (100 mL)
and a 20% w/v aqueous Na2CO3 solution (100 mL). The aqueous
solution was further extracted with CH2Cl2 (2 ϫ 100 mL). The
combined organic extracts were washed sequentially with saturated
NaHCO3 solution (100 mL), water (100 mL), and brine (100 mL),
before being dried (MgSO4) and concentrated in vacuo. Purifica-
tion by column chromatography (neutral alumina, 1.5% MeOH/
CH2Cl2 eluent) afforded 3 as a fine brown powder (0.697 g, 62%).
1H NMR (250 MHz, CDCl3): δ ϭ 2.84Ϫ2.87 (m, 4 H, CH2N),
3.64Ϫ3.81 (m, 12 H, CH2O), 4.10Ϫ4.14 (m, 4 H, PhOCH2), 6.25
(m, 2 H, pyr-H), 6.55 (m, 2 H, pyr-H), 6.94 (s, 1 H, Ph-H), 6.97 (s,
1 H, Ph-H), 6.99 (2 H, pyr-H), 9.64 (br. s, 2 H, pyr-NH) ppm. 13C
NMR (62 MHz, CDCl3): δ ϭ 49.2, 49.3, 68.3, 68.4, 68.6, 69.0,
70.0, 70.1, 71.2, 70.7, 106.7, 106.8, 109.8, 111.2, 120.1, 129.3, 136.7,
142.0, 151.3 ppm. HRMS (CIϩ) calcd. for C26H32N5O5 [M ϩ H]ϩ:
494.2403; found m/z: 494.2408. UV/Vis: λmax (CH3CN, ε/Ϫ1
cmϪ1) ϭ 270 (25700), 405 (20900) nm.
The
appropriate
dinitro-3n-benzo-n-crown
(12؊15)
(2.35Ϫ7.0 mmol) or 1,2-dimethoxy-4,5-dinitrobenzene (3.58 g,
15.70 mmol), and 10% Pd/C (170Ϫ500 mg) were suspended in eth-
anol (33Ϫ135 mL) and glacial acetic acid (2Ϫ7 mL) and shaken in
a Parr hydrogenation apparatus at 50 psi H2 pressure and ambient
temperature for 44 h. The resultant diamine was assumed to form
in quantitative yield and was used immediately in the subsequent
reaction. The reaction mixture was filtered through a pad of Celite
into the next reaction vessel and washed with ethanol (50 mL). 1,2-
Bis(1H-pyrrol-2-yl)ethanedione (20) (1.1Ϫ7.24 mmol) dissolved in
glacial acetic acid (80Ϫ180 mL) was added to the solution and the
resultant mixture was heated at reflux for 24 h. The reaction mix-
ture was allowed to cool, and then concentrated in vacuo. The re-
maining residue was redissolved in a mixture of CH2Cl2 (75 mL)
and water (75 mL). The aqueous layer was further extracted with
CH2Cl2 (3 ϫ 75 mL). The combined organic extracts were washed
sequentially with saturated NaHCO3 solution (100 mL), water
(100 mL), and brine (100 mL), before being dried (MgSO4) and
concentrated in vacuo.
18-Crown-6-dipyrrolylquinoxaline (1): The intermediate diamine 16
was synthesized from 12 (2.82 g, 7.0 mmol) according to the gen-
eral procedure given above. This was then treated with 20 (0.60 g,
3.2 mmol). Product 1 was obtained in pure form as a fine brown
Aza-15-crown-5-dipyrrolylquinoxaline (4): The intermediate di-
amine 19 was synthesized from 15 (0.84 g, 2.35 mmol) according
to the general procedure given above. This was then treated with
20 (0.20 g, 1.1 mmol) to yield the crude product as the acetate salt.
Workup was effected in the manner described for 3. Purification by
column chromatography (neutral alumina, 1.5% MeOH/CH2Cl2,
eluent) then afforded 4 as a fine red-brown powder (0.234 g, 49%).
1H NMR (250 MHz, CDCl3): δ ϭ 2.98Ϫ3.01 (m, 4 H, CH2N),
3.84Ϫ3.88 (m, 4 H, CH2O), 3.97Ϫ4.01 (m, 4 H, CH2O), 4.22Ϫ4.26
(m, 4 H, PhOCH2), 6.27 (m, 2 H, pyr-H), 6.72 (m, 2 H, pyr-H),
6.97 (m, 2 H, pyr-H), 7.13 (s, 2 H, Ph-H), 9.49 (br. s, 2 H, pyr-
NH) ppm. 13C NMR (62 MHz, CDCl3): δ ϭ 49.0, 67.5, 68.7, 69.3,
106.6, 109.8, 111.3, 120.1, 129.3, 136.8, 141.8, 151.5 ppm. HRMS
powder (1.58 g, 100%). 1H NMR (250 MHz, CDCl3):
δ ϭ
3.68Ϫ3.84 (m, 16 H, CH2O), 4.10Ϫ4.13 (m, 4 H, PhOCH2), 6.26
(m, 2 H, pyr-H), 6.55 (m, 2 H, pyr-H), 6.96 (s, 2 H, Ph-H), 6.99
(m, 2 H, pyr-H), 9.64 (br. s, 2 H, pyr-NH) ppm. 13C NMR
(62 MHz, CDCl3): δ ϭ 68.8, 69.0, 70.4, 70.9, 71.1, 106.9, 109.8,
111.2, 120.2, 120.2, 129.3, 136.7, 141.9, 151.5 ppm. HRMS (CIϩ):
calcd. for C26H31N4O6 [M ϩ H]ϩ 495.2244; found m/z: 495.2235.
C26H30N4O6·H2O: calcd. C 60.93, H 6.29, N 10.93; found C 60.97,
H 6.16, N 10.51. UV/Vis: λmax (CH3CN, ε/Ϫ1 cmϪ1) ϭ 271
(28900), 407 (23300) nm.
Crystallization of 1: Receptor 1 was dissolved in boiling acetone
and then allowed to cool to room temp. Yellow-green crystals of 1, (CIϩ) calcd. for C24H28N5O4 [M ϩ H]ϩ 450.2141; found m/z:
suitable for X-ray diffraction analysis, were obtained by letting the
solution stand overnight.
450.2142. UV/Vis: λmax (CH3CN, ε/Ϫ1 cmϪ1) ϭ 270 (24800), 404
(13300) nm.
3776
Eur. J. Org. Chem. 2002, 3768Ϫ3778